Enhanced functional and structural properties of high-density lipoproteins from runners and wrestlers compared to throwers and lifters

  • Lee, Hwa-Hyung (School of Biotechnology, Yeungnam University) ;
  • Park, Jeong-Euy (Division of Cardiology, Samsung Medical Center, Sungkyunkwan University School of Medicine) ;
  • Choi, In-Ho (School of Biotechnology, Yeungnam University) ;
  • Cho, Kyung-Hyun (School of Biotechnology, Yeungnam University)
  • Published : 2009.09.30


Plasma high-density lipoprotein cholesterol (HDL-C) levels are inversely correlated with the risk of cardiovascular disease, and are known to increase with repetitive exercise. In the current study, HDL fractions from athletes' sera were isolated and compared as a function of the type of sport (runners [n = 10], throwers [n = 10], wrestlers [n = 10], and weight lifters [n = 8]), and as an age- and gender-matched reference group (n = 14). Among athletes, HDL from runners had the strongest antioxidant activity. Immunodetection showed that runners and wrestlers had the highest levels of apoA-I and lowest levels of apoA-II in their HDL. Electron microscopy also revealed that HDL2 of runners and wrestlers were the largest in size. In conclusion, although all athlete groups had significantly better serum lipid/lipoprotein profiles than the reference group, runners and wrestlers had the most desirable lipoprotein function and structure, including antioxidant activity, HDL-associated enzyme activities and increased particle size.


  1. Gordon, T., Castelli, W. P., Hjortland, M. C., Kannel, W. B. and Dawber, T. R. (1977) High density lipoprotein as a protective factor against coronary heart disease. Am. J. Med. 62, 707-714
  2. Lewis, G.F. and Rader, D.J. (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ. Res. 96, 1221-1232
  3. Leaf, D. A. (2003) The effect of physical exercise on reverse cholesterol transport. Metabolism 52, 950-957
  4. Benzie, I. F. and Strain, J. J. (1996) The ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assay. Anal Biochem. 239, 70-76
  5. Boileau, R. A., Mayhew, J. L., Riner, W. F. and Lussier, L. (1982) Physiological characteristics of elite middle and long distance runners. Can. J. Appl. Sports Sci. 7, 167-172
  6. Cho, K. H., Lee, J. Y., Choi, M. S., Cho, J. M., Lim, J. S. and Park, Y. B. (1998) A peptide from hog plasma that inhibits human cholesteryl ester transfer protein. Biochim. Biophys. Acta. 1391, 133-144
  7. Eckerson, H. W., Wyte, C. M. and La Du, B. N. (1983) The human serum paraoxonase/arylesterase polymorphism. Am. J. Hum. Genet 35, 1126-1138
  8. Kosek, A. B., Durbin, D. and Jonas, A. (1999) Binding affinity and reactivity of lecithin cholesterol acyltransferase with native lipoproteins. Biochem. Biophys. Res. Commun. 258, 548-551
  9. Ribas, V., Sanchez-Quesada, J. L., Anton, R., Camacho, M., Julve, J., Escola-Gil, J. C., Vila, L., Ordonez-Llanos, J. and Blanco-Vaca, F. (2004) Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Circ. Res. 95, 789-797
  10. Sasaki, J., Tanabe, Y., Tanaka, H., Saku, K., Shindo, M. and Arakawa, K. (1988) Elevated levels of HDL2-cholesterol and apoA-I in national class Japanese male marathon runners. Atherosclerosis 70, 175-177
  11. Olchawa, B., Kingwell, B. A., Hoang, A., Schneider, L., Miyazaki, O., Nestel, P. and Sviridov, D. (2004) Physical fitness and reverse cholesterol transport. Arterioscler Thromb. Vasc. Biol. 24, 1087-1091
  12. Havel, R. J., Eder, H. A. and Bragdon, J. H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353
  13. Matz, C. E. and Jonas, A. (1982) Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 257, 4535-4540
  14. Barter, P. J., Nicholls, S., Rye, K. A., Anantharamaiah, G. M., Naval, M. and Fogelman, A. M. (2004) Antiinflammatory properties of HDL. Circ. Res. 95, 764-772
  15. Seip, R. L., Moulin, P., Cocke, T., Tall, A., Kohrt, W. M., Mankowitz, K., Semenkovich, C. F., Ostlund, R. and Schonfeld, G. (1993) Exercise training decreases plasma cholesteryl ester transfer protein. Arterioscler Thromb. 13, 1359-1367
  16. Park, S. H., Kim, J. R., Park, J. E. and Cho, K. H. (2007) A Caucasian male with very low blood cholesterol and low apoA-II without evidence of atherosclerosis. Eur. J. Clin. Invest. 37, 249-256
  17. Despres, J. P., Lamarche, B., Bergeron, J., Gagnon, J., Leon, A. S., Rao, D. C., Skinner, J. S., Wilmore, J. H. and Bouchard, C. (2001) Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the health, risk factors, exercise training and genetics (HERITAGE) family study. Arterioscler. Thromb. Vasc. Biol. 21, 1226-1232
  18. Han, J. M., Jeong, T. S., Lee, W. S., Choi, I. and Cho, K. H. (2005) Structural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound states. J. Lipid Res. 46, 589-596
  19. Markwell, M. A., Haas, S. M., Bieber, L. L. and Tolbert, N. E. (1978) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 87, 206-210
  20. Avogaro, P., Cazzolato, G., Bittolo Bon, G. and Belussi, F. (1979) Levels and composition of HDL2 and HDL3 and other major lipoprotein classes in survivors of myocardial infarction. Artery 5, 495-503
  21. Kraus, W. E., Houmard, J. A., Duscha, B. D., Knetzger, K. J., Wharton, M. B., McCartney, J. S., Bales, C. W., Henes, S., Samsa, G. P., Otvos, J. D., Kulkarni, K. R. and Slentz, C. A. (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. N. Engl. J. Med. 347, 1483-1492
  22. Horswill, C. A. (1992) Applied physiology of amateur wrestling. Sports Med. 14, 114-143
  23. Kelley, G. A. and Kelley, K. S. (2006) Aerobic exercise and lipids and lipoproteins in men: a meta-analysis of randomized controlled trials. J. Mens Health Gend. 3, 61-70
  24. Morton, R. E. (1999) Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein. Curr. Opin. Lipidol. 10, 321-327
  25. Williams, P. T. (1996) High-density lipoprotein cholesterol and other risk factors for coronary heart disease in female runners. N. Engl. J. Med. 334, 1298-1303

Cited by

  1. Innovative approach to interpret the variability of biomarkers after ultra-endurance exercise: the multifactorial analysis vol.8, pp.6, 2014,
  2. Consumption of high-dose vitamin C (1250 mg per day) enhances functional and structural properties of serum lipoprotein to improve anti-oxidant, anti-atherosclerotic, and anti-aging effects via regulation of anti-inflammatory microRNA vol.6, pp.11, 2015,
  3. Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I vol.32, pp.4, 2013,
  4. High-density lipoprotein cholesterol (HDL-C) in cardiovascular disease: effect of exercise training vol.5, pp.3, 2016,
  5. Dysfunctional Lipoproteins from Young Smokers Exacerbate Cellular Senescence and Atherogenesis with Smaller Particle Size and Severe Oxidation and Glycation vol.140, pp.1, 2014,
  6. Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process vol.11, pp.10, 2016,
  7. Rapid detection of dysfunctional high-density lipoproteins using isoelectric focusing-based microfluidic device to diagnose senescence-related disease vol.32, pp.23, 2011,
  8. Weight Loss and Exercise Alter the High-Density Lipoprotein Lipidome and Improve High-Density Lipoprotein Functionality in Metabolic Syndrome vol.38, pp.2, 2018,
  9. Consumption of Cuban Policosanol Improves Blood Pressure and Lipid Profile via Enhancement of HDL Functionality in Healthy Women Subjects: Randomized, Double-Blinded, and Placebo-Controlled Study vol.2018, pp.1942-0994, 2018,